ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 규모는 최근 급속히 확대되고 있습니다. 2024년의 13억 9,000만 달러에서 2025년에는 16억 9,000만 달러로 성장하고, CAGR 21.8%를 나타낼 것으로 전망되고 있습니다. 지난 몇 년간의 성장은 장기 점적이 필요한 만성 질환 증가, 입원 환자에서 외래 점적 센터로의 전환, 종양학 및 면역학에서의 생물학적 요법의 성장, 유행 후 원격 관리 모델의 채택, 간호사 부족으로 인한 원격 모니터링의 필요성 증가로 인한 것으로 예측됩니다.
인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 36억 7,000만 달러에 달하고, CAGR은 21.4%를 나타낼 전망입니다. 예측 기간중의 성장 요인으로서는 재택치료 프로그램의 확충과 적용 범위의 확대, 암 치료나 자가면역 질환용 특수 점적 약제의 지속적 성장, 간호직의 인재 부족과 불타 증후군의 심각화, 안전성과 치료 성과에 연동한 가치 기반형 의료의 인센티브, 적절한 재택 점적을 촉진하는 지불자측의 예측 기간의 주요 동향으로는 컴퓨터 비전 기술을 이용한 혈관외 누출·침윤의 검출, 캐뉼라 부위의 조직 변화를 감시하는 멀티스펙트럼 광학 센싱, 디바이스상 해석을 위한 센서 패치 탑재 엣지 AI, 폐색·에어 인라인·유량 이상을 예측하는 분석 모델, Fast Healthcare Interoperability Resources(FHIR) 용도 운용성
원격 의료 서비스의 확대는 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장의 성장을 가속할 것으로 예측됩니다. 원격 의료 서비스는 디지털 통신 기술을 활용하여 원격 의료 상담, 모니터링 및 치료를 제공합니다. COVID-19 팬데믹 중에 도입된 규제 변경과 상환 정책은 의료 제공업체와 환자 모두에게 접근성과 재정적 실현 가능성을 높였습니다. 인공지능(AI) 기반 원격 환자 정맥 내 모니터링은 IV 요법 실시간 추적, 합병증 자동 감지, 의료 제공업체에게 실용적인 지식 제공, 가상 케어 플랫폼과의 통합을 가능하게 함으로써 원격 의료를 지원하여 적시 개입, 환자 안전 향상, 재택 및 외래 치료의 효율적인 관리를 보장합니다. 예를 들어, 2023년 4월에 미국 비영리 단체 FAIR Health Inc.가 발표한 바에 따르면 전국적인 원격의료 이용률은 7.3% 증가했고 의료청구 건수에 차지하는 비율은 2022년 12월의 5.5%에서 2023년 1월에는 5.9%로 상승했습니다. 이와 같이 원격 의료 서비스의 확대가 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장의 성장을 견인하고 있습니다.
웨어러블 건강 기술의 보급이 시장 성장을 가속할 것으로 예측됩니다. 스마트 워치 및 피트니스 트래커와 같은 웨어러블 디바이스는 실시간으로 건강 지표를 모니터링합니다. 건강 의식 증가와 실시간 건강 정보 수요가 이러한 기술의 채택을 추진하고 있습니다. 웨어러블 건강 기술은 생리 데이터를 지속적으로 수집하여 원격 환자 정맥 내 모니터링을 지원하여 비정상 검출, IV 치료 최적화, 상시 대면 모니터링 없이 시기 적절하고 개별화된 개입을 가능하게 합니다. 예를 들면, 2025년 4월에 영국 의회 하원 도서관이 발표한 보고서에 의하면, 2023년부터 2024년에 걸쳐, NIHR(영국 국립 의료 연구 기구)과 UKRI(영국 연구 혁신 기구)는 허약상태나 장기적인 신체장애를 가진 사람들의 자립을 지원하는 웨어러블 기술의 개발에 임하는 10개의 연구 프로젝트에 약 1,500만 달러(1,150만 파운드)를 투자했습니다. 따라서 웨어러블 건강 기술의 보급은 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장의 성장에 기여합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 성장률 분석
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 실적 : 규모와 성장(2019-2024년)
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 구성 요소별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
하드웨어
소프트웨어
서비스
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 배포 모드별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
On-Premise
클라우드 기반
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
진료소
재택치료 환경
외래 수술 센터(ASC)
기타 용도
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
의료 제공업체
환자
기타 최종 사용자
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 하드웨어 유형별, 분석과 예측
환자 모니터링 장치
센서 및 주입 펌프
통신 장치
데이터 저장 시스템
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 소프트웨어 유형별, 분석과 예측
예측 분석 소프트웨어
임상 의사 결정 지원 소프트웨어
원격 모니터링 소프트웨어
데이터 관리 소프트웨어
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 서비스 유형별, 분석과 예측
구현 및 통합 서비스
유지보수 및 지원 서비스
교육 및 훈련 서비스
원격 모니터링 서비스
제7장 지역별/국가별 분석
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 경쟁 구도
인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장 : 기업 프로파일
Medtronic plc : 개요, 제품 및 서비스, 전략 및 재무 분석
Siemens Healthineers AG : 개요, 제품 및 서비스, 전략 및 재무 분석
GE HealthCare Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Koninklijke Philips NV : 개요, 제품 및 서비스, 전략 및 재무 분석
Baxter International Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
B. Braun Melsungen AG
Terumo Corporation
Nipro Corporation
Epic Systems Corporation
ICU Medical Inc.
InfuSystem Holdings Inc.
AlayaCare Inc.
Huma Therapeutics Ltd.
Health Recovery Solutions Inc.
Arcomed AG
VitalConnect Inc.
Cloud DX Inc.
Empatica Srl
AccuHealth Inc.
Serum Tracker Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장(2029년) : 새로운 기회를 제공하는 국가
인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장(2029년) : 새로운 기회를 제공하는 부문
인공지능(AI) 기반 원격 환자 정맥 내 모니터링 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring is a system that employs AI algorithms to continuously track and analyze IV therapy data in real time. It can identify irregularities, predict potential complications, and optimize fluid or medication delivery based on patient-specific patterns. The technology combines sensors, data analytics, and automated alerts to enhance safety and efficiency in IV treatment management.
The primary components of AI-enhanced remote patient intravenous (IV) monitoring include hardware, software, and services. Hardware comprises physical equipment and devices that collect, process, and support system operations, such as infusion pumps and wearable patient monitors. These systems can be deployed on-premises or via cloud platforms. They are applied in various settings, including hospitals, clinics, homecare, ambulatory surgical centers, and others, and are used by diverse end-users such as healthcare providers and patients.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market statistics, including artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring industry global market size, regional shares, competitors with the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market share, artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring industry. This artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market size has grown rapidly in recent years. It will grow from $1.39 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 21.8%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases requiring long-term infusions, the shift from inpatient to outpatient infusion centers, growth in oncology and immunology biologic therapies, post-pandemic adoption of remote care models, and nurse staffing shortages creating a greater need for remote oversight.
The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market size is expected to see rapid growth in the next few years. It will grow to $3.67 billion in 2029 at a compound annual growth rate (CAGR) of 21.4%. The growth during the forecast period can be attributed to the expansion of hospital-at-home programs and coverage, continued growth of specialty infusion drugs for oncology and autoimmune diseases, ongoing nursing workforce shortages and burnout, value-based care incentives linked to safety and outcomes, and payer policies encouraging appropriate home-based infusions. Key trends in the forecast period include computer vision-based detection of extravasation and infiltration, multispectral optical sensing to monitor tissue changes at the cannula site, edge AI on sensor patches for on-device analytics, predictive analytics models for occlusions, air-in-line, and flow anomalies, and electronic health record interoperability using Fast Healthcare Interoperability Resources (FHIR) application programming interfaces.
The expansion of telehealth services is expected to drive the growth of the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market. Telehealth services utilize digital communication technologies to provide remote medical consultations, monitoring, and treatment. Regulatory changes and reimbursement policies introduced during the COVID-19 pandemic have increased accessibility and financial viability for both providers and patients. AI-enhanced remote patient IV monitoring supports telehealth by enabling real-time tracking of IV therapy, detecting complications automatically, providing actionable insights to healthcare providers, and integrating with virtual care platforms to ensure timely interventions, improved patient safety, and efficient management of home-based and outpatient treatments. For example, in April 2023, FAIR Health Inc., a US-based non-profit organization, reported that national telehealth use increased by 7.3%, rising from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. The expansion of telehealth services is therefore driving growth in the AI-enhanced remote patient IV monitoring market.
The proliferation of wearable health technologies is expected to propel market growth. Wearable devices such as smartwatches and fitness trackers monitor health metrics in real time. Increasing health awareness and the demand for real-time health insights are driving the adoption of these technologies. Wearable health technologies support remote patient IV monitoring by continuously collecting physiological data, enabling the detection of anomalies, optimization of IV treatments, and timely, personalized interventions without constant in-person supervision. For instance, in April 2025, the UK Parliament's House of Commons Library reported that between 2023 and 2024, the NIHR and UKRI invested approximately USD 15 million (£11.5 million) in 10 research projects developing wearable technologies to support independence for people living with frailty or long-term physical disabilities. The proliferation of wearable health technologies is thus contributing to the growth of the AI-enhanced remote patient IV monitoring market.
Increasing healthcare expenditure is expected to support the growth of the AI-enhanced remote patient IV monitoring market. Rising financial resources in healthcare reflect growing demand for advanced medical technologies and services aimed at improving patient outcomes, enhancing treatment efficiency, and supporting AI-enabled remote monitoring. Higher healthcare expenditure facilitates investment in advanced technologies, digital infrastructure, and staff training to ensure more efficient and accurate patient care. For example, in June 2025, the Centers for Medicare & Medicaid Services reported that in 2023, national health expenditures increased by 7.5% to reach $4.9 trillion, averaging $14,570 per person and representing 17.6% of GDP. Medicare spending rose by 8.1% to $1,029.8 billion, accounting for 21% of total national health expenditures. Increasing healthcare expenditure is therefore driving the growth of the AI-enhanced remote patient IV monitoring market.
Major players in the artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market are Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Epic Systems Corporation, ICU Medical Inc., InfuSystem Holdings Inc., AlayaCare Inc., Huma Therapeutics Ltd., Health Recovery Solutions Inc., Arcomed AG, VitalConnect Inc., Cloud DX Inc., Empatica S.r.l., AccuHealth Inc., Serum Tracker Inc.
North America was the largest region in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market consists of revenues earned by entities by providing services such as continuous IV flow monitoring, AI-powered predictive analytics, remote patient monitoring, automated alerts and notifications, data management and reporting, telehealth integration, device management and support, and medication management support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced remote patient intravenous (IV) monitoring market also includes sales of flow meters, pressure transducers, wireless control interfaces for infusion pumps, cloud-integrated drug infusion systems, and AI-enhanced remote monitoring platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced remote patient intravenous (iv) monitoring market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Component: Hardware; Software; Services
2) By Deployment Mode: On-Premises; Cloud-Based
3) By Application: Hospitals; Clinics; Homecare Settings; Ambulatory Surgical Centers; Other Applications
4) By End-User: Healthcare Providers; Patients
Subsegments:
1) By Hardware: Patient Monitoring Devices; Sensors And Infusion Pumps; Communication Devices; Data Storage Systems
2) By Software: Predictive Analytics Software; Clinical Decision Support Software; Remote Monitoring Software; Data Management Software
3) By Services: Implementation And Integration Services; Maintenance And Support Services; Training And Education Services; Remote Monitoring Services
Companies Mentioned: Medtronic plc; Siemens Healthineers AG; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; Baxter International Inc.; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; Epic Systems Corporation; ICU Medical Inc.; InfuSystem Holdings Inc.; AlayaCare Inc.; Huma Therapeutics Ltd.; Health Recovery Solutions Inc.; Arcomed AG; VitalConnect Inc.; Cloud DX Inc.; Empatica S.r.l.; AccuHealth Inc.; Serum Tracker Inc.
4. Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring Growth Analysis And Strategic Analysis Framework
5.1. Global Artificial Intelligence (AI)-Enhanced Remote Patient Intravenous (IV) Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
